SIERRA ONCOLOGY, INC.
1820 Gateway Drive, Suite 110
San Mateo, California 94404
November 10, 2021
Via EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Office of Life Sciences
| Re: | Sierra Oncology, Inc. |
Registration Statement on Form S-3
Filed November 5, 2021
File No. 333-260799
Requested Date: November 12, 2021
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
Sierra Oncology, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to make the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Registrant hereby authorizes Michael Nordtvedt, an attorney with the Registrant’s outside legal counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, to orally modify or withdraw this request for acceleration.
| Sincerely, | ||
| Sierra Oncology, Inc. | ||
| By: | /s/ Sukhi Jagpal | |
| Sukhi Jagpal | ||
| Chief Financial Officer | ||
cc: Stephen G. Dilly, President and Chief Executive Officer | ||
Sierra Oncology, Inc.
Michael Nordtvedt
Wilson Sonsini Goodrich & Rosati, Professional Corporation
